Two major pharmaceutical companies developing advanced-stage R&D on Alzheimer’s disease have just pulled the plug on their research. The reason why their approach to Alzheimer’s, Aducanumab, failed is because it didn’t account for a factor that is central
to R&D conducted by biotechnology Company ProMIS Neurosciences Inc.
(TSX:PMN, OTCQB:ARFXF, Forum).
Preclinical studies show the Company's lead antibody candidate, PMN310,
demonstrates a high degree of binding to toxic oligomers from Alzheimer's disease brains without binding to plaque or other non-toxic forms of the toxic oligomer form of
amyloid beta (Aβ).
Not only has an important competitor dropped out of the race to find an Alzheimer’s
treatment, the reason for failure suggests that ProMis is on the right track with its own
research.
Stockhouse is joined by Company President and CEO, Dr. Elliot Goldstein to learn
more about ProMIS’ research and potential to combat Alzheimer’s Disease.
There’s Gold in Them Thar Hills! The ‘Unique Business Model’ in the Historic Cariboo
The Company that’s Elevating Digital Media to a Whole New Level
Accelerating the Business of Agriculture and Agri-tech
The Company that’s Elevating Digital Media to a Whole New Level
New Copper/Tin Discovery Sparks Promise for Mining Revival in Cornwall UK
AI & IoT Innovations Saving Retail During Coronavirus And Beyond
How Augmented Reality is Driving the New Economy
How Ontario’s Top Cannabis Edibles Producer is Growing During Coronavirus
Crossing the Rubicon into the Super Premium Cannabis Space
PROFIT! Eps. 18: Scott Montgomery CEO WellteQ
PROFIT! Eps. 17: Allan Hartley, CEO of Bay Talent Group
PDAC Interview Greg Rickford, Minister of Energy, Mines, Northern Development and Indigenous Affairs
The Company Creating a Real Buzz in the Exploding Agri-Tech Marketplace
Threat Detection Technology Designed to Save Lives
PROFIT! Eps. 16: Scott Burton, CEO of Askott Entertainment
Forging a New Path into the Medical Cannabis Space
PROFIT! Eps. 15: George Robinson, CEO Ravenquest Biomed Inc.
StockTalk Exclusive! Cannabis Industry Icon Steve DeAngelo
PROFIT! Eps. 14: Craig Goodwin, CEO Naturally Splendid Enterprises Ltd.
PROFIT! Eps. 13: Ross McElroy, President / COO Fission Uranium Corp.
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Aligned Money Show
Dubai Property Podcast
IBKR Podcasts
The Ramsey Show
The Clark Howard Podcast